LABx Corp. was founded in 2018 by Cornell University-educated biomedical and electrical engineer Tom Navasero. The company—known to be at the forefront of the AIDS epidemic, as well as several dengue outbreaks—continues to play a vital role in the infectious-diseases field by providing and developing innovative testing solutions.
At LABx, we are committed to delivering next-level diagnostic solutions anchored on the following:
Healthcare should be within reach of every citizen. This means decentralizing health-related services from hospitals and clinics and bringing them closer to home.
In order for accurate diagnostics to be accessible, they first have to be affordable. As such, LABx provides products and services at price points that level the playing field.
Proper diagnostics should not merely be quick and responsive. They should, first and foremost, be accurate. Only then can one determine the proper course of medical action.
By 2030, we wish to empower every Filipino through diagnostic products and services that are accessible, affordable, and accurate. Only when they are able to get unassailable diagnosis would universal healthcare be a full-fledged reality.
DR. JOSE MIGUEL VERGARA, MD
firstname.lastname@example.org or email@example.com
Clipp Bldg. 11th Ave. cor. 39th St., BGC 1634